Research Article
Prognostic Value of Metastatic No.8p LNs in Patients with Gastric Cancer
Table 4
The comparison of GC patient survival outcomes in No.8p+ group and in No.8p− group at stage III/IV.
| | No.8p+ group | No.8p− group | value | | 3-year OS (%) | 3-year OS (%) |
| Total | 26.0 | 53.0 | 0.005 | Gender | | | 0.040 | Male | 27.0 | 51.0 | | Female | 25.0 | 56.0 | | Age (years) | | | 0.011 | >60 | 14 | 40 | | ≤60 | 31 | 61 | | Gastrectomy | | | | Total Gastrectomy | 25 | 61 | 0.006 | Subtotal gastrectomy | 27 | 43 | | Pathological degree | | | | Differentiated | 33 | 55 | 0.041 | Undifferentiated | 10 | 47 | | Curative degree | | | 0.003 | R0 | 19 | 55 | | R1/R2 | 0 | 40 | | Lymphadenectomy | | | | D1+ | 22 | 51 | 0.115 | D2+ | 29 | 57 | |
|
|
pTNM stage in the No.8p− group is based on the Japanese classification of gastric carcinoma: 3rd English edition.
|